MSCs alleviate pulmonary fibrosis in mice as evidenced by the significant decrease in collagen deposition, lowered expressions of TGF-β1, vimentin, and p-Smad2/3, and increased expression of E-cadherin [79]. The gene discussed is SMAD2; the disease is pulmonary fibrosis.